Editorial Open Access
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Dec 27, 2024; 16(12): 3655-3657
Published online Dec 27, 2024. doi: 10.4240/wjgs.v16.i12.3655
Preoperative gastric retention in endoscopic retrograde cholangiopancreatography patients: Assessing risks and optimizing outcomes
Nuo-Ya Zhou, Bing Hu, Department of Gastroenterology and Hepatology/Medical Engineering Integration Laboratory of Digestive Endoscopy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
ORCID number: Nuo-Ya Zhou (0009-0007-7330-8400); Bing Hu (0000-0002-9898-8656).
Author contributions: Zhou NY drafted the manuscript; Hu B revised the manuscript; both authors have read and approved the final manuscript.
Supported by National Natural Science Foundation of China, No. 82170675.
Conflict-of-interest statement: All authors have no conflict of interest to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Bing Hu, MD, Professor, Department of Gastroenterology and Hepatology/Medical Engineering Integration Laboratory of Digestive Endoscopy, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, Sichuan Province, China. hubing@wchscu.edu.cn
Received: July 19, 2024
Revised: August 27, 2024
Accepted: September 13, 2024
Published online: December 27, 2024
Processing time: 131 Days and 7.6 Hours

Abstract

This article is a comment on the article by Jia et al, aiming at establishing a predictive model to predict the occurrence of preoperative gastric retention in endoscopic retrograde cholangiopancreatography preparation. We share our perspectives on this predictive model. First, further differentiation in predicting the severity of gastric retention could enhance clinical outcomes. Second, we ponder whether this predictive model can be generalized to predictions of gastric retention before various endoscopic procedures. Third, large datasets and prospective clinical validation are needed to improve the prediction model.

Key Words: Endoscopic retrograde cholangiopancreatography; Preoperative gastric retention; Prediction model; Adverse event; Operation safety; Comment

Core Tip: Jia et al conducted a retrospective analysis of patients undergoing endoscopic retrograde cholangiopancreatography preparation, identified factors influencing preoperative gastric retention, and developed a predictive model for its occurrence. We have three key points to share after reading this enlightening paper.



INTRODUCTION

Endoscopic retrograde cholangiopancreatography (ERCP) remains a pivotal diagnostic and therapeutic tool in the management of pancreatic and biliary diseases. ERCP-related adverse events primarily include post-ERCP pancreatitis, cholangitis, bleeding, and perforation[1]. Gastric retention can lead to restricted visibility, operational difficulties, and an increased risk of surgical complications. Preoperative gastric retention and its associated adverse events have not been adequately recognized during ERCP procedure.

COMMENT ON A RECENR PUBLISHED ARTICLE

We read with great interest an article titled “Establishment of predictive models and determinants of preoperative gastric retention in endoscopic retrograde cholangiopancreatography” by Jia et al[2]. They conducted a retrospective analysis on 190 patients who underwent ERCP preparation and analyzed factors influencing preoperative gastric retention in ERCP, revealing that factors such as gender, primary disease, jaundice, opioid use, and gastrointestinal obstruction contribute to the risk of gastric retention. Then they established a predictive model to predict the occurrence of preoperative gastric retention in ERCP. After reading this enlightening paper, we have three views to share.

First, further differentiation in predicting the severity of gastric retention could enhance clinical outcomes. In clinical practice, for patients with mild gastric retention, it is crucial to shorten the duration of the ERCP procedure, prevent intraoperative vomiting, and immediately halt the procedure in case of complications. For patients with severe gastric retention, the ERCP procedure should be terminated immediately. Fasting should be continued postoperatively, and a gastrointestinal decompression tube should be left in place with negative pressure applied to suction the gastric contents. ERCP should be performed again once no food residue can be suctioned out[3]. Due to the differing treatment measures, we believe that predicting various degrees of gastric retention would be more beneficial.

Second, we ponder whether this predictive model can be generalized to predictions of gastric retention before different endoscopic procedures. The generalization of a predictive model refers to its ability to perform well on new, unseen data that was not used during the training phase. In other words, a model with good generalization accurately predicts outcomes across different datasets, rather than just performing well on the data that it was trained on. Even though the dataset was based on ERCP patients, those predictive factors, which are gender, primary disease, jaundice, opioid use, and gastrointestinal obstruction, have minor connection with ERCP operation itself. The prediction model could be tested on different endoscopic procedures to test its generalization.

Third, large retrospective datasets and prospective clinical validation are needed to improve the prediction model. This single-center, retrospective dataset contains only 190 patients. The accessibility of retrospective data is uncontrollable, and the same indicator may not be judged consistently in retrospective data, limiting its clinical utility. Larger datasets from multiple medical centers may enhance the predictive ability by incorporating more patients and diverse data. Furthermore, prospective clinical trials can better validate its efficacy in real clinical scenarios, evaluating model ability by indicators judged consistently.

CONCLUSION

The work by Jia et al[2] provides an insightful method for predicting the occurrence of preoperative gastric retention in ERCP, helping us assess risks and optimize ERCP outcomes. The continuous improvement and validation of the predictive model in clinical practice are very important.

Footnotes

Provenance and peer review: Invited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Gastroenterology and hepatology

Country of origin: China

Peer-review report’s classification

Scientific Quality: Grade B

Novelty: Grade B

Creativity or Innovation: Grade A

Scientific Significance: Grade B

P-Reviewer: Anestiadou E S-Editor: Lin C L-Editor: Wang TQ P-Editor: Xu ZH

References
1.  Dumonceau JM, Kapral C, Aabakken L, Papanikolaou IS, Tringali A, Vanbiervliet G, Beyna T, Dinis-Ribeiro M, Hritz I, Mariani A, Paspatis G, Radaelli F, Lakhtakia S, Veitch AM, van Hooft JE. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2020;52:127-149.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 249]  [Cited by in F6Publishing: 389]  [Article Influence: 97.3]  [Reference Citation Analysis (0)]
2.  Jia Y, Wu HJ, Li T, Liu JB, Fang L, Liu ZM. Establishment of predictive models and determinants of preoperative gastric retention in endoscopic retrograde cholangiopancreatography. World J Gastrointest Surg. 2024;16:2574-2582.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
3.  Chen C, Ye ZX, Liu XL, Fu Tt, Wen JL, Hu B. [Risk factors of non-obstructive gastric retention before endoscopic treatment in patients with biliopancreatic disease: a matched case-control study]. Zhongguo Xiaohua Neijing Zahi. 2020;37:562-566.  [PubMed]  [DOI]  [Cited in This Article: ]